Published 2011 | Version v1
Journal article

Intestinal tumours induced in ApcMin/+ mice by X-rays and neutrons

  • 1. Health Protection Agency, Centre for Radiation, Chemical and Environmental Hazards, Chilton, Didcot, Oxfordshire (United Kingdom)
  • 2. Nuclear Research and Consultancy Group, Petten (Netherlands)

Description

Purpose: To compare the development of intestinal adenomas following neutron and X-ray exposure of ApcMin/+ mice (Apc – adenomatous polyposis coli; Min – multiple intestinal neoplasia). Materials and methods: Adult mice were exposed to acute doses of X-rays or fission neutrons. Tumour counting was undertaken 200 days later and samples were taken for Loss of Heterozygosity (LOH) analysis. Results: Tumour numbers (adenomas and microadenomas) increased by 1.4-fold, 1.7-fold, 2.7-fold and 9-fold, after 0.5, 1, 2 and 5 Gy X-rays, respectively, and by 2.4-fold and 5.7-fold, after 0.5 and 1 Gy fission neutrons, respectively. LOH analysis of tumours from neutron-exposed mice showed that 63% had lost Apc and 90% (cf. 53% in controls) had lost D18mit84, a marker for Epb4.1l4a/NBL4 (erythrocyte protein band 4.1-like 4a/novel band 4.1-like 4), known to be involved in the Wnt (wingless-related mouse mammary tumour virus integration site) pathway. Some tumours from neutron-exposed mice appeared to have homozygous loss of some chromosomal markers. Conclusions: X-ray or fission neutron irradiation results in strongly enhanced tumour multiplicities. Comparison of tumour yields indicated a low Relative Biological Effectiveness of around 2–8 for fission neutrons compared with X-rays. LOH in intestinal tumours from neutron-exposed mice appeared to be more complex than previously reported for tumours from X-irradiated mice. (authors)

Availability note (English)

Also available at: https://doi.org/10.3109/09553002.2011.542542

Additional details

Identifiers

Publishing Information

Journal Title
International Journal of Radiation Biology
Journal Volume
87
Journal Issue
4
Journal Page Range
p. 385-399
ISSN
0955-3002